AzTrials
AzTrials

Mild - Major DepressionPsiTODNCT02091856

Internet-delivered Psychotherapy for Depression

A study testing Cognitive Behavioral Therapy (CBT) in people with Mild - Major Depression, run by West University of Timisoara at 1 site in Romania.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Project aim: To compare the effectiveness and acceptability of a conventional and a religious internet-supported cognitive behavior therapy (iCBT) for depression in Romania. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mild - Major Depression
What is being tested?
Cognitive Behavioral Therapy (CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
79 participants
Where
1 siteRomania
Study dates
Mar 2014to Sep 2015
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • be fluent in Romanian
  • be over 18 years
  • have a diagnosis of current major depression disorder
  • have access to an Internet connected computer

Who cannot join

  • suicidal ideation
  • ongoing psychological treatment for depression
  • other primary disorder that need treatment
  • obstacle to participation (i.e., long travel plans)
  • recent change in psychiatric medication (i.e., during the last 6 weeks)

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • West University of Timisoara

    Timișoara, Timiș County, 300223

Other trials in Romania

About this study

Official title: Internet-delivered Cognitive-Behavioral Therapy for Depression: A Randomized Controlled Trial (PsiTOD)

Project aim: To compare the effectiveness and acceptability of a conventional and a religious internet-supported cognitive behavior therapy (iCBT) for depression in Romania.

Read the detailed description

Previous studies suggest that incorporating religious beliefs into conventional CBT appears to be helpful for religious individuals. In order to have two active comparable interventions the investigators added to the conventional CBT a similar set of exercises devised from the positive psychology paradigm.

Being tested
Cognitive Behavioral Therapy (CBT)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behavioral Therapy (CBT)Behavioural

    Cognitive behavioral therapy (CBT) represents a psychotherapeutic approach that helps patients understand the thoughts and feelings that influence behaviors. The underlying concept behind CBT is that thoughts and feelings play a fundamental role in behavior. Beyond the conventional CBT techniques proven effective for MDD, the Positive CBT intervention includes set of exercises devised from the positive psychology paradigm. Similarly, the Christian CBT intervention includes a comparable set of exercises rooted on the general Christian belief.

Study groups in NCT02091856
Study groupRoleWhat they receive
Conventional-CBT (C-CBT)ExperimentalThis arm represents the classical Cognitive Behavioral Therapy (CBT) approach for major depression disorder (MDD) plus a set of exercises devised from the mindfulness paradigm.
Receives: Behavioral: Cognitive Behavioral Therapy (CBT)
Religious CBT (R-CBT)ExperimentalThis arm represents the classical Cognitive Behavioral Therapy (CBT) approach for major depression disorder (MDD) plus a set of exercises devised from the general Christian belief.
Receives: Behavioral: Cognitive Behavioral Therapy (CBT)
Wait List Control Group (WLCG)No interventionThis arm represents the wait-list comparison group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Beck Depression Inventory-II (BDI-II)

    The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

    This represents the post-intervention assessment.

    Measured: Absolute values (average score) of Back Depression Inventory-II at 11 weeks (post-intervention)

  2. Beck Depression Inventory II (BDI-II)

    The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

    This represents the measure of depression at 6 month after the intervention.

    Measured: Absolute values (average score) of BDI-II at 37 weeks (follow-up)

Secondary outcomes (3)
  1. Beck Anxiety Inventory (BAI)

    The Beck Anxiety Inventory (BAI) was designed to measure participant's level of anxiety. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of anxiety, while high scores are associated with high levels of anxiety.

    This represent the post-intervention assessment.

    Measured: Absolute values (average score) of Back Anxiety Inventory at 11 weeks (post-intervention)

  2. Quality of Life Inventory (QOLI)

    The Quality of Life Inventory (QOLI) is an established rating scale of self-perceived quality of life across 16 domains. The scale is unidimensional and the total score rages from -6 to +6. Low scores are associated with low self-perceived life quality, while high scores are associated with high self-perceived life quality.

    This represents the post-intervention assessment.

    Measured: Absolute values (average score) of QOLI at 11 weeks (post-intervention)

  3. Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)

    The Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR) was designed to measure participant's level of depression. The scale is unidimensional and the total score rages from 0 to 27. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

    This represents a secondary outcome measure for depression taken immediately after the intervention.

    Measured: Absolute values (average score) of QIDS-SR after 11 weeks (post-treatment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionSep 2015
  4. Study completionSep 2015

Why it stopped: We have recruited and treated 79 participants

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
79 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02091856
Sponsor's protocol ID
WUTimisoara-PsiTOD
Acronym
PsiTOD
Status last verified
Feb 2016
First submitted
5 Mar 2014
Last updated
28 Jun 2018
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behavioral Therapy (CBT) in people with Mild - Major Depression, run by West University of Timisoara at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Mar 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Beck Depression Inventory-II (BDI-II) (time frame: Absolute values (average score) of Back Depression Inventory-II at 11 weeks (post-intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in